- Tack Endovascular System®
- Clinical Trials
- Peripheral Artery Disease
- Contact Us
This animation is provided for general information only. It is not intended to provide clinical instructions for use (IFU). Always read and understand the IFU supplied with the device prior to use.
The Tack Endovascular System® offers physicians a new option for treating peripheral artery disease. It is designed specifically to spot treat dissections following POBA and DCB angioplasty in peripheral arteries with minimal stress to the vessels. Currently, the Tack Endovascular System is approved for investigational use in the United States and has obtained a CE Mark in Europe.
Over 70% less metal left behind than stenting means a minimal amount of foreign material in the artery, which reduces inflammation.12
Less force on the vessel wall reduces vessel trauma and reaction.3
Focused treatment allows physicians to “spot treat” the vessel only where dissections are present.4
Flexibility with self-sizing technology allows one Tack implant to fit arteries ranging from 2.5mm to 6.0mm (6F device) in diameter and 1.5mm to 4.5mm (4F device) in diameter. This eliminates the need to precisely size the device to the arterial diameter, which is necessary with conventional stents.
The Tack Endovascular System was conceived by Dr. Peter Schneider, a renowned vascular surgeon interested in effectively repairing arterial dissections following angioplasty. This device is investigating his idea of enhancing POBA or DCB angioplasty by using less metal with less force to yield better healing and preserve retreatment options.
CAUTION: Investigational device. Limited by Federal (United States) law to investigational use.